The Safety, Tolerability, and Pharmacokinetic Study of SC1011 in Healthy Subjects.

Inclusion Criteria: * Males or females, of any race, between 18 and 45 years of age, inclusive, at Screening. * Body mass index between 18.0 and 32.0 kg/m2, inclusive, at Screening. * In good health, determined by no clinically significant findings from medical history, physical examination, 12-lead ECG, vital sign measurements, and clinical laboratory evaluations at Screening and/or Check-in as assessed by the Investigator. * Females will be nonpregnant and nonlactating. Females of childbearing potential and male subjects will agree to use contraception. * Able to comprehend and willing to sign an informed consent form (ICF) and to abide by the study restrictions. Exclusion Criteria: * Significant history or clinical manifestation of any metabolic, allergic, dermatological, hepatic, renal, hematological, pulmonary, cardiovascular, gastrointestinal, neurological, respiratory, endocrine, or psychiatric disorder, as determined by the Investigator (or designee). * History of significant hypersensitivity, intolerance, or allergy to any drug compound, food, or other substance. * Alcohol consumption of \> 21 units per week for males and \> 14 units for females. One unit of alcohol equals 12 oz (360 mL) beer, 1½ oz (45 mL) liquor, or 5 oz (150 mL wine), or a positive alcohol breath test at Check-in. * Any screening laboratory or ECG results are not within the normal reference range and are considered clinically significant. * Participants who participated in other clinical trials within 3 months prior to administration. * Blood donation or blood loss exceeding 400 mL within 2 months prior to administration. * Participants who smoked, drank alcohol, tea, food or drink containing xanthine or caffeine, or had strenuous exercise, or had other factors affecting drug absorption, distribution, metabolism and excretion 2 days before drug administration. * Subjects who, in the opinion of the Investigator (or designee), should not participate in this study.